This 5.25-hour curriculum provides the foundational and introductory knowledge needed for pharmacists (PharmDs and RPhs).
Pharmacists: Introductory Curriculum on Alcohol Use Disorder and Medications for Alcohol Use Disorders
Created by: American Society of Addiction Medicine
June 2026
Overview
Designed for pharmacists (PharmDs and RPhs) who support the treatment of alcohol use disorder (AUD) and medications for alcohol use disorder (MAUD), this curriculum provides the foundational knowledge needed to optimize medication‑related AUD care.
The target audience for this introductory level activity includes clinical healthcare professionals who prescribe medications in outpatient or inpatient settings.
This activity addresses the following ACGME Competencies: Patient Care and Procedural Skills; Medical Knowledge; Interpersonal and Communication Skills; and Systems-Based Practice
Learning Objectives
Upon completion, learners will be able to:
Determine the most suitable FDA-approved medication to treat alcohol use disorder based on the patient’s clinical presentation and treatment goals.
Discuss clinical considerations for prescribing medications to treat alcohol use disorder to patients with comorbid conditions.
Recognize signs, symptoms, and risks factors for alcohol withdrawal syndrome.
Registration Deadline: 04/25/2029
Close Access Date: 05/25/2029
Instructions
Click on the Contents tab to begin this activity.
Click the first section, Screening, Goal Setting, & Conversations About Alcohol Use. On the first component, Digital Resource- Alcohol Use Disorder: Understanding Stigmatizing Language, click Download Digital Resource to get started.
Expand and click each of the curriculum sections and components to review the enduring trainings, online modules, downloadable digital resources, and mini videos.
Once you've reviewed all sections, click Post-Test, Evaluation & Claim Credit section.
Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
Click Complete GPRA Survey to provide valuable activity feedback.
Click Complete Evaluation and Complete Evaluation - Presenters to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.
For Pharmacists ONLY: Complete the task entitled "Enter Pharmacist CPE Monitor Information (Pharmacists Only)". Pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist CPE Monitor Information survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact pcss@asam.org.
Note for pharmacists: For courses offering CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab.
Alyssa Falleni
PharmD
Alyssa Falleni, PharmD, is a clinical pharmacist who received her Doctorate of Pharmacy from the University of Rhode Island. She recently completed a two-year fellowship in Health Professions Education, Evaluation, and Research in Substance Use Disorders and Related Harms at the VA Connecticut Healthcare System. She holds a clinical instructor appointment at the Yale School of Medicine in the Department of Psychiatry and works as an outpatient HIV Pharmacist at Hartford Healthcare, Connecticut. Her research and clinical interests are in improving medication access for people who use substances and identifying and addressing social determinants of health.
No Relevant Financial Disclosures.
Joshua Lee, MD, MSc
Joshua D. Lee MD, MSc is a Professor in the departments of Population Health and Medicine/General Internal Medicine and Clinical Innovation at the NYU Grossman School of Medicine. He is Director of the NYU Fellowship in Addiction Medicine and Co-Director of DPH’s Section on Tobacco, Alcohol, and Drug Use. He is a clinician-researcher focused on addiction pharmacotherapies in primary care and criminal justice populations and leads the NYUGSOM Hub of the NIDA Justice and Community Opioid Innovation Network. He is a Science Advisor at Oar Health, an alcohol treatment provider.
Dislcosures: Indivior, in-kind study drug donation; Alkermes, in-kind study drug donation; Oar Health, Clinical Advisor
Lara Ray
PhD
Dr. Lara Ray received her PhD in Clinical Psychology from the University of Colorado at Boulder. Dr. Ray completed a predoctoral clinical internship at Brown University Medical School, where she stayed for a postdoctoral fellowship at the Brown University Center for Alcohol and Addiction Studies. After her postdoctoral fellowship, Dr. Ray joined the faculty at the UCLA Clinical Psychology Program, where she is now a Full Professor. Dr. Ray also has academic appointments at the UCLA Department of Psychiatry and Human Behavior and the UCLA Brain Research Institute. Dr. Ray has an active program of research on the clinical neuroscience of addiction. Her laboratory combines experimental psychopharmacology with behavioral genetic and neuroimaging methods to ascertain the mechanisms underlying addictive disorders in humans and apply these insights to treatment development. Dr. Ray has over 250 peer-reviewed publications and book chapters. Her program of research is funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) as well as the National Institute on Drug Abuse (NIDA). Dr. Ray has received research excellence awards from the American Psychological Association (APA), the Research Society on Alcoholism (RSA), and the American College on Neuropsychopharmacology (ACNP).
No Relevant Financial Disclosures.
Melissa Weimer, Do, MCR, DFASAM
PCSS-MAUD Medical Director
Yale School of Medicine
Lamia Haque, MD, MPH
Hepatologist, Addiction Medicine Specialist, Assistant Professor of Internal Medicine
Yale School of Medicine
No relevant financial disclosures
Julie Byler, D.O., FASAM
Adventist Improving Addiction Care Team (IMPACT) Lead
Adventist Health Portland
No Relevant Financial Disclosures
Tessa Steel
MD, MPH
Tessa Steel, MD, MPH is an Assistant Professor, physician-scientist, and Pulmonary Critical Care Medicine doctor at Harborview Medical Center, a county safety-net hospital operated by the University of Washington in Seattle. She is board-certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine. Her clinical and research interests include improving hospital-based treatments for alcohol withdrawal syndrome and using hospitalizations to help people with addiction launch their process of recovery.
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credits Available
Pharmacists: 5.25 Credits
Certified Counselors: NBCC Contact Hours Not Offered American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
NAADAC: CE Credits not offered
Certificates for other professions
All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This 60 minute training discusses how organizations can successfully integrate medications for alcohol use disorder (MAUD) and other evidence-based AUD treatment services into the Certified Community Behavioral Health Clinic (CCBHC) model.
Integrating MAUD and AUD Treatment into the CCBHC Model: Lessons Learned from Organizational Change and Clinical Integration
Host: The National Council on Mental Wellbeing
Recorded: June 30, 2026 Enduring Training
Overview
This training discusses how organizations can successfully integrate medications for alcohol use disorder (MAUD) and other evidence-based AUD treatment services into the Certified Community Behavioral Health Clinic (CCBHC) model. The session highlights lessons learned from organizational change and clinical integration efforts at Integrity House, a CCBHC in New Jersey, providing a real-world example of how to strengthen care coordination, increase treatment engagement, and address common implementation challenges across multidisciplinary teams. Participants explore evidence-based approaches to treating AUD within a CCBHC setting, examine organizational barriers to implementing MAUD services and strategies for supporting accessible, patient-centered care, and learn practical approaches to workforce development and systems coordination that can help sustain services over time. Attendees will leave with actionable strategies to expand access to care and improve outcomes for individuals with AUD.
The target audience for this introductory level activity includes: All types of healthcare professionals.
The ACGME Competencies include: Patient Care and Procedural Skills, and Systems-based Practice
Learning Objectives
Upon completion, learners will be able to:
Describe evidence-based approaches to treating AUD within a CCBHC setting.
Identify organizational and other barriers to implementing MAUD services.
Explain strategies to support low-barrier, client-centered access to MAUD and AUD treatment.
Discuss the role of workforce development, overdose prevention, and systems coordination in sustaining AUD services.
Registration Deadline: 08/30/2027
Close Access Date: 09/30/2027
Instructions
Click on the Contents tab to begin this activity.
Click View On-Demand Session to watch the training.
Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click Claim Certificate of Completion to view/print certificate.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact pcssmaud@asam.org.
Katie Kena, LCSW
Program Director
Integrity House
Katie Kena is a Licensed Clinical Social Worker (LCSW) specializing in trauma, PTSD, depression, and anxiety. She is the Project Director at Integrity House and operates a private practice, KT Psychotherapy LLC, located in the East Brunswick/West Windsor area of New Jersey.
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This 5.5-hour curriculum provides the foundational and introductory knowledge needed for counselors/therapists (LPC, LMHC, LCPC, PhD, PsyD), social workers (LCSWs, LMSWs), and other licensed counseling professionals.
Social Workers & Counselors: Introductory Curriculum on Alcohol Use Disorder
Created by: American Society of Addiction Medicine
June 2026
Overview
Designed for counselors/therapists (LPC, LMHC, LCPC, PhD, PsyD), social workers (LCSWs, LMSWs), and other licensed counseling professionals new to treating alcohol use disorder (AUD), this 5-hour and 30-minute curriculum provides the foundational knowledge needed to support high‑quality, person‑centered AUD care. This curriculum features multiple learning formats, including enduring trainings, interactive online modules, mini videos (<10 mins), and downloadable digital resources.
The target audience for this introductory level activity includes counselors/therapists, social workers, and other licensed counseling professionals.
This activity addresses the following ACGME Competencies: Patient Care and Procedural Skills; Medical Knowledge; Interpersonal and Communication Skills; and Systems-Based Practice
Learning Objectives
Upon completion, learners will be able to:
Describe how screening, brief intervention, and referral to treatment can be integrated into inpatient and outpatient settings to identify and support patients struggling with alcohol use.
Apply strategies and skills to guide conversations with patients about their alcohol use.
Discuss the FDA-approved medications to treat alcohol use disorder.
Registration Deadline: 04/25/2029
Close Access Date: 05/25/2029
Instructions
Click on the Contents tab to begin this activity.
Click the first section, Screening, Goal Setting, & Conversations About Alcohol Use. On the first component, Digital Resource- Alcohol Use Disorder: Understanding Stigmatizing Language, click Download Digital Resource to get started.
Expand and click each of the curriculum sections and components to review the enduring trainings, online modules, downloadable digital resources, and mini videos.
Once you've reviewed all sections, click Post-Test, Evaluation & Claim Credit section.
Click Complete GPRA Survey to complete the PCSS-MAUD GPRA survey.
Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the PCSS-MAUD e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact pcss@asam.org.
Note for pharmacists: For courses offering CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab.
Alyssa Peterkin, MD
Hospitalist
Boston Medical Center
Alyssa Peterkin, MD is an Instructor of Medicine Boston University School of Medicine and an internist at Boston Medical Center. Currently, she also serves as an associate program director for Grayken Addiction Medicine fellowship. She spends her clinical time working as a hospitalist, attending on the inpatient addiction consultation service and working in the substance use disorder urgent care. Her interests include educating learners at all levels and expanding access to addiction treatment.
No Relevant Financial Disclosures.
Carla B. Marienfeld, MD, DFAPA, DFASAM:
Carla Marienfeld, MD, is an addiction psychiatrist and Clinical Professor at the University of California, San Diego (UCSD). She edited two books: Motivational Interviewing for Clinical Practice and Absolute Addiction Psychiatry Review: An Essential Board Exam Study Guide. She has been highly involved in the education of colleagues and trainees, and she is the fellowship director for the UCSD Addiction Psychiatry Fellowship. Dr. Marienfeld completed a fellowship in addiction psychiatry and residency training in psychiatry at Yale University. Her medical degree with honors is from Baylor College of Medicine in Houston, Texas. Dr. Marienfeld is a consultant for and has stock in CARI Health.
Sharde McLeish
MD
Dr. McLeish specializes in addiction medicine. Her main clinical interests are cocaine, opioid, and tobacco use disorders, community outreach, education, and wellness. Dr. McLeish received her MD from St. George’s University School of Medicine in Grenada, West Indies. She did an internal medicine residency at Englewood Hospital and an addiction medicine fellowship at Yale School of Medicine in New Haven, CT. Dr. McLeish is a member of the American College of Academic Addiction Medicine, the American College of Physicians, and the American Society of Addiction Medicine. She joined Englewood Health Physician Network in 2024.
No disclosures.
Cara Borelli
DO
Dr. Borelli is a core faculty member in addiction medicine at Yale University School of Medicine. She trained in emergency medicine at UT Health San Antonio and completed an addiction medicine fellowship at Icahn School of Medicine in New York City, New York. Her clinical work is on the inpatient Yale Addiction Medicine Consult Service in New Haven, Connecticut. In this role, she works on an interdisciplinary team and precepts trainees who span the spectrum of medical training, including first-year medical students, medical students, and resident physicians on the Yale Collaborative Behavioral Health and Addiction Medicine Program (CHAMP) pathway, consult-liaison psychiatry fellows, palliative care fellows, and addiction medicine fellows.
No disclosures.
Dr. Brian Hurley
Brian Hurley, MD, MBA, DFASAM, FAPA, is an addiction physician and the Medical Director of the Los Angeles County Department of Public Health Division of Substance Abuse Prevention and Control. Brian is a Volunteer Assistant Clinical Professor of Addiction Medicine at the David Geffen School of Medicine, UCLA, and the 2023-2025 President of the American Society of Addiction Medicine (ASAM). Dr. Hurley is a member of the Motivational Interviewing Network of Trainers and regularly conducts motivational interviewing training throughout the United States.
Trina Fullard
Charlotte Rescue Mission
Trina Fullard serves as the Chief Executive Officer at Charlotte Rescue Mission, overseeing clinical programming for various programs. She is a Licensed Clinical Addiction Specialist and Certified Clinical Supervisor in North Carolina. With extensive experience in adolescent care and substance use disorder treatment, she has worked at the Marriott Foundation, Greenbriar Treatment Center, and McLeod Addictive Disease Center. Trina graduated from Washington and Jefferson College and the University of Maryland, College Park. She actively participates in community engagement through numerous councils and committees, including the ASAM Fundamentals of Addiction Medicine Planning Committee.
Kenneth Morford, MD, FASAM
Assistant Professor
Yale School of Medicine
No Relevant Financial Disclosures
Itai Danovitch, MD, MBA, FAPA, DFASAM
Psychiatrist
Cedars Sinai
Itai Danovitch, MD, MBA is Professor and Chair of the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center in Los Angeles, California. Dr. Danovitch’s clinical practice and research focuses on substance use disorders, as well as the integration of medical and mental health services. His studies are funded by the National Institutes of Health (NIH).
Dr. Danovitch is the author of over 90 articles and book chapters and co-editor of two books on substance use disorders. He is a Distinguished Fellow of the American Society of Addiction Medicine, a Distinguished Fellow of the American Psychiatric Association, past president of the California Society of Addiction Medicine, and a recipient of the Golden Apple Award for Excellence in Teaching.
Subject matter expert for the Peer Recovery Center of Excellence
Recovery Support Peer Specialist and Supervisor at Communities for Recovery playing a pivotal role in developing and implementing programs to support individuals on their recovery journey.
Peer Recovery Support Specialist trainer since 2018, playing a crucial role as writer for the Texas Recovery Support Peer Specialist 2024 curriculum
Areas of expertise include strategies to reduce the risk of harm, peer supervision, and workforce development.
Patsy Dolan, LCSW
Executive Director
SIMS Foundation
Patsy Dolan Bouressa is a Licensed Clinical Social Worker Supervisor with over 20 years of experience as a counselor, including over 9 years’s experience working specifically with individuals in the music industry and their partners and other gig workers. Throughout her career, she’s worked extensively with clients facing the unique challenges of career transitions, depression, anxiety, substance use disorder, and trauma.
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credits Available
Social Workers: 5.5 Credits
Certified Counselors: 5.5 NBCC Contact Hours American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
NAADAC: 5.5 CE Credits
Certificates for other professions
All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1224.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education. Speaker disclosures are listed on the speakers tab.
This 8.25-hour curriculum provides advanced education for prescribers (MDs, DOs, APRNs, and PAs) to care for patients with AUD, including complex cases, co-occurring conditions, and other common challenges of treating AUD.
Prescribers: Advanced Curriculum on Alcohol Use Disorder and Medications for Alcohol Use Disorders
Created by: American Society of Addiction Medicine
June 2026
Overview
Designed for prescribers (MDs, DOs, APRNs, and PAs) who already have foundational knowledge and experience in treating alcohol use disorder (AUD) and/or prescribing medications for AUD (MAUD), this 8-hour and 15-minute curriculum offers advanced education to help prescribers manage complex cases, co-occurring conditions, and other common challenges of treating AUD. This curriculum features multiple learning formats, including enduring trainings, interactive online modules, mini videos (<10 mins), and downloadable digital resources.
The target audience for this advanced level activity includes clinical healthcare professionals who prescribe medications in outpatient or inpatient settings.
This activity addresses the following ACGME Competencies: Patient Care and Procedural Skills; Medical Knowledge; Interpersonal and Communication Skills; and Systems-Based Practice
Learning Objectives
Upon completion, learners will be able to:
Discuss strategies to manage alcohol withdrawal syndrome in outpatient settings.
Determine safe MAUD implementation among patients with advanced liver disease.
Examine treatment approaches for alcohol use disorder and co-occurring substance use disorders and psychiatric conditions.
Registration Deadline: 05/24/2029
Close Access Date: 07/24/2029
Instructions
Click on the Contents tab to begin this activity.
Click the first section, Screening, Goal Setting, & Conversations About Alcohol Use. On the first component, Digital Resource- Alcohol Use Disorder: Understanding Stigmatizing Language, click Download Digital Resource to get started.
Expand and click each of the curriculum sections and components to review the enduring trainings, online modules, downloadable digital resources, and mini videos.
Once you've reviewed all sections, click Post-Test, Evaluation & Claim Credit section.
Click Complete GPRA Survey to provide valuable activity feedback.
Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact pcss@asam.org.
Note for pharmacists: For courses offering CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab.
Stephen Holt
MD, MS, FACP
No Relevant Financial Disclosures.
Brian Fuehrlein, MD, PhD
Associate Professor Psychiatry
Yale School of Medicine
Dr. Fuehrlein graduated from the M.D. Ph.D. program at the University of Florida in 2008, adult psychiatry residency program at the University of Texas Southwestern Medical Center in 2012 and addiction psychiatry fellowship at Yale University in 2013. He is currently an Associate Professor and the director of the psychiatric emergency room at the VA Connecticut. Dr. Fuehrlein has a strong interest in medical student and resident education, particularly surrounding addiction psychiatry and serves on multiple local and national committees in this role. In 2017 he was awarded the Irma Bland award for excellency in psychiatry resident education through the APA. In 2018 he was awarded the Clerkship Faculty Teaching Award for Outstanding Medical Student Educator and Role Model. He is also passionate about emergency psychiatry and substance use disorders and has presented and published his work surrounding opioid use disorder in the emergency room setting. In 2019 he was inducted into the American College of Psychiatrists, an organization that recognizes excellence in clinical practice, research, academic leadership, or teaching.
No Relevant Financial Disclosures.
Reuben Strayer
MD, FACEP
Maimonides Medical Center
No Relevant Financial Disclosures
Itai Danovitch, MD, MBA, FAPA, DFASAM
Psychiatrist
Cedars Sinai
Itai Danovitch, MD, MBA is Professor and Chair of the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center in Los Angeles, California. Dr. Danovitch’s clinical practice and research focuses on substance use disorders, as well as the integration of medical and mental health services. His studies are funded by the National Institutes of Health (NIH).
Dr. Danovitch is the author of over 90 articles and book chapters and co-editor of two books on substance use disorders. He is a Distinguished Fellow of the American Society of Addiction Medicine, a Distinguished Fellow of the American Psychiatric Association, past president of the California Society of Addiction Medicine, and a recipient of the Golden Apple Award for Excellence in Teaching.
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Certified Counselors: NBCC Contact Hours Not Offered American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
NAADAC: CE Credits not offered
Maintenance of Certification (MOC)/Continuing Certification Program (CCP)
This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
ABIM MOC Points: 8.25 Medical Knowledge | 8.25 Patient Safety
ABP MOC: 8.25 Lifelong Learning & Self-Assessment
ABS Continuing Certification: 8.25 Accredited CME
ABA MOCA 2.0®*: 8.25 Lifelong Learning | 8.25 Patient Safety
Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.
American Board of Addiction Medicine (ABAM)
American Board of Preventative Medicine (ABPM)
American Board of Psychiatry and Neurology (ABPN)
Royal College of Physicians and Surgeons of Canada (RCPSC)
Certificates for other professions
All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1224.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This 50-minute training examines the clinical implications of alcohol use disorder (AUD) among patients receiving care in opioid treatment programs (OTPs) and office-based opioid use disorder treatment (OBOT) settings
Managing Alcohol Use Disorder in Opioid Use Disorder Treatment Settings
Host: American Academy of Addiction Psychiatry
Recorded: June 10, 2026 Enduring Training
Overview
This training examines the clinical implications of alcohol use disorder (AUD) among patients receiving care in opioid treatment programs (OTPs) and office-based opioid use disorder treatment (OBOT) settings. Participants learn about the epidemiology of AUD in individuals with opioid use disorder (OUD) and the impact of this co-occurrence on patient outcomes. The session reviews best practices for screening, diagnosis, and biochemical testing for AUD in patients receiving medications for opioid use disorder (MOUD). Finally, the webinar will provide practical, evidence-based strategies for integrating medications for alcohol use disorder (MAUD) into OTP and OBOT settings to support comprehensive, patient-centered care.
The target audience for this introductory level activity includes: All types of healthcare professionals.
The ACGME Competencies include: Patient Care and Procedural Skills, and Systems-based Practice
Learning Objectives
Upon completion, learners will be able to:
Describe the epidemiology of alcohol use disorder (AUD) in individuals with opioid use disorder (OUD) and the clinical implications of co-occurrence
Apply diagnostic and biochemical testing principles for AUD in patients receiving medications for opioid use disorder (MOUD)
Implement evidence-based strategies for integrating medications for alcohol use disorder (MAUD) into opioid treatment programs (OTPs) and office based OUD treatment settings (OBOTs)
Registration Deadline: 08/30/2027
Close Access Date: 09/30/2027
Instructions
Click on the Contents tab to begin this activity.
Click View On-Demand Session to watch the training.
Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click Claim Certificate of Completion to view/print certificate.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact pcssmaud@asam.org.
David Marcovitz, MD
Associate Professor of Psychiatry and Behavioral Sciences
Vanderbilt University
David Marcovitz, MD, is the current medical director of the Vanderbilt University Hospital Addiction Consult Service and Bridge Clinic. After graduating from Vanderbilt University School of Medicine, he completed general psychiatry residency at the MGH-McLean program at Harvard Medical School and an addiction psychiatry fellowship at Partners Healthcare / Harvard Medical School in Boston. His primary clinical and research interests include providing high quality addiction care, developing innovative models of collaborative care with other medical specialties, and medical education. He has worked in both academic and private, as well as inpatient and outpatient addiction treatment facilities. He became waivered to prescribe buprenorphine in 2014 and became a certified course instructor in 2018. He also serves on the Board of Directors of the American Academy of Addiction Psychiatry.
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This 75-minute training equips providers to effectively identify, assess, and manage alcohol use disorder using evidence-based screening, diagnosis, treatment, and care coordination strategies in the primary care setting.
Determining the Appropriate Referral for AUD in Primary Care
Host: Addiction Technology Transfer Center
Recorded: June 2, 2026 Enduring Training
Overview
This training focuses on the identification and management of alcohol use disorder (AUD) in primary care settings, highlighting the prevalence and impact of AUD and the critical role primary care plays in addressing it. Using real-world clinical scenarios, participants explore evidence-based screening tools to identify at-risk patients and apply diagnostic criteria to assess AUD and determine severity. The session will guide learners in matching patients to appropriate levels of care, including referral decisions using the ASAM Criteria. Participants also review appropriate pharmacologic treatments and brief behavioral interventions for AUD, while building skills to support patient engagement, address ambivalence, and coordinate care effectively. In addition, the training will examine common co-occurring physical, mental health, and substance use comorbidities to support more comprehensive and integrated care.
The target audience for this introductory level activity includes: All types of healthcare professionals.
The ACGME Competencies include: Patient Care and Procedural Skills, and Systems-based Practice
Learning Objectives
Upon completion, learners will be able to:
Describe the prevalence and impact of AUD and the case for addressing in primary care.
Explain role of screening tools for identifying at-risk patients.
Apply criteria to diagnose AUD and match severity to appropriate level of care.
Identify appropriate medications and brief behavioral interventions for AUD.
Understand common co-occurring physical, mental, and SUD co-morbidities.
Registration Deadline: 08/30/2027
Close Access Date: 09/30/2027
Instructions
Click on the Contents tab to begin this activity.
Click View On-Demand Session to watch the training.
Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click Claim Certificate of Completion to view/print certificate.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact pcssmaud@asam.org.
Itai Danovitch, MD, MBA, FAPA, DFASAM
Psychiatrist
Cedars Sinai
Itai Danovitch, MD, MBA is Professor and Chair of the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center in Los Angeles, California. Dr. Danovitch’s clinical practice and research focuses on substance use disorders, as well as the integration of medical and mental health services. His studies are funded by the National Institutes of Health (NIH).
Dr. Danovitch is the author of over 90 articles and book chapters and co-editor of two books on substance use disorders. He is a Distinguished Fellow of the American Society of Addiction Medicine, a Distinguished Fellow of the American Psychiatric Association, past president of the California Society of Addiction Medicine, and a recipient of the Golden Apple Award for Excellence in Teaching.
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This 5.25-hour curriculum provides the foundational and introductory knowledge needed for prescribers (MDs, DOs, APRNs, and PAs) to care for patients with AUD.
Prescribers: Introductory Curriculum on Alcohol Use Disorder and Medications for Alcohol Use Disorders
Created by: American Society of Addiction Medicine
June 2026
Overview
Designed for prescribers (MDs, DOs, APRNs, and PAs) new to treating alcohol use disorder (AUD) and/or prescribing medications for AUD (MAUD), this 5-hour and 15-minute curriculum provides the foundational knowledge needed to care for patients with AUD. This curriculum features multiple learning formats, including enduring trainings, interactive online modules, mini videos (<10 mins), and downloadable digital resources.
The target audience for this introductory level activity includes clinical healthcare professionals who prescribe medications in outpatient or inpatient settings.
This activity addresses the following ACGME Competencies: Patient Care and Procedural Skills; Medical Knowledge; Interpersonal and Communication Skills; and Systems-Based Practice
Learning Objectives
Upon completion, learners will be able to:
Describe current recommendations for screening patients for risky alcohol use.
Examine the neurobiological mechanism underlying alcohol withdrawal syndrome.
Determine the most suitable FDA-approved medication to treat alcohol use disorder based on the
patient’s clinical presentation and treatment goals.
Registration Deadline: 04/25/2029
Close Access Date: 05/25/2029
Instructions
Click on the Contents tab to begin this activity.
Click the first section, Screening, Goal Setting, & Conversations About Alcohol Use. On the first component, Digital Resource- Alcohol Use Disorder: Understanding Stigmatizing Language, click Download Digital Resource to get started.
Expand and click each of the curriculum sections and components to review the enduring trainings, online modules, downloadable digital resources, and mini videos.
Once you've reviewed all sections, click Post-Test, Evaluation & Claim Credit section.
Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact pcss@asam.org.
Note for pharmacists: For courses offering CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab.
Shawn Cohen
MD, FASAM
Shawn Cohen, MD, FASAM is an Instructor of Medicine at Yale School of Medicine whose primary clinical responsibilities are on the Yale Addiction Medicine Consult Service. He is board-certified in Internal Medicine and Addiction Medicine. He has an interest in improving care in the hospital for people who use drugs, low barrier outpatient care, and low dose initiation of buprenorphine.
No Relevant Financial disclosures.
Tessa Steel
MD, MPH
Tessa Steel, MD, MPH is an Assistant Professor, physician-scientist, and Pulmonary Critical Care Medicine doctor at Harborview Medical Center, a county safety-net hospital operated by the University of Washington in Seattle. She is board-certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine. Her clinical and research interests include improving hospital-based treatments for alcohol withdrawal syndrome and using hospitalizations to help people with addiction launch their process of recovery.
No Relevant Financial Disclosures.
Alyssa Peterkin, MD
Hospitalist
Boston Medical Center
Alyssa Peterkin, MD is an Instructor of Medicine Boston University School of Medicine and an internist at Boston Medical Center. Currently, she also serves as an associate program director for Grayken Addiction Medicine fellowship. She spends her clinical time working as a hospitalist, attending on the inpatient addiction consultation service and working in the substance use disorder urgent care. Her interests include educating learners at all levels and expanding access to addiction treatment.
No Relevant Financial Disclosures.
Stephen Holt
MD, MS, FACP
No Relevant Financial Disclosures.
Melissa B. Weimer
DO, MCR, FASAM
Yale School of Medicine
No Relevant Financial Disclosures.
Kevin Sevarino, MD, PhD (DFAAAP, FASAM, FAPA)
Medical Director
American Academy of Addiction Psychiatry (AAAP)
No Relevant Financial Disclosures.
Christine Harsell, DNP, ANP-BC
Medical Director/Nurse Practitioner
Spectra Health
Christine Harsell DNP, ANP-BC is a nurse practitioner and medical director at an FQHC in North Dakota. She oversees an integrated primary care setting that provides substance use disorder (SUD) services including medications for alcohol use disorder. She works regionally to offer SBIRT and Medications for Addiction Treatment (MAT) implementation training and technical assistance and has been a content expert and case presenter on a variety of Project ECHO sessions related to SUD.
No Relevant Financial Disclosures.
Dale Walaszek, PA-C
Physician Associate
Central Peninsula Hospital
Dale Walaszek is a Physician Associate who works in Soldotna, Alaska at a hospital based Behavioral Health Department providing addiction medicine care. The services provided include acute detox, MOUD/MAUD, and primary health care. Coaching clients who struggle with addictions has been both the most challenging and rewarding experience of Dale's 27 year career.
No Relevant Financial Disclosures.
Carolyn J. Swenson, MSPH, MSN, RN
University of Colorado School of Medicine
Carolyn Swenson provides consultation, training, and coaching on substance use and suicide prevention, and motivational interviewing. She completed master’s degrees in nursing and public health and is a certified Question-Persuade-Refer (QPR) suicide prevention trainer. Her past work includes perinatal and pediatric nursing; public health nursing with migrant farmworkers and on the Navajo reservation, and refugee relief work in Sudan; epidemiology research; and quality improvement with clinics, hospitals, and public health departments. Born and raised in Minnesota, she now resides in Denver, Colorado.
No Relevant Financial Disclosures.
Anne Dowton, MD
Director of Addiction Medicine
Hartford Hospital
Dr. Dowton is the Director of Addiction Medicine at Hartford Hospital. She directs the inpatient Addiction Medicine Consult Service at Hartford Hospital and provides care to patients with substance use disorders who are admitted to the acute care setting. She holds dual board-certification in Internal Medicine from the American Board of Internal Medicine and Addiction Medicine from the American Board of Preventative Medicine.
Dr. Dowton received her medical degree from Tufts University School of Medicine and then completed her Internal Medicine residency at Tufts Medical Center in Boston, MA. After residency, she completed the Addiction Medicine Fellowship at Yale School of Medicine.
She is an Assistant Professor of Medicine at the University of Connecticut School of Medicine.
No Relevant Financial Disclosures.
Alyssa Falleni
PharmD
Alyssa Falleni, PharmD, is a clinical pharmacist who received her Doctorate of Pharmacy from the University of Rhode Island. She recently completed a two-year fellowship in Health Professions Education, Evaluation, and Research in Substance Use Disorders and Related Harms at the VA Connecticut Healthcare System. She holds a clinical instructor appointment at the Yale School of Medicine in the Department of Psychiatry and works as an outpatient HIV Pharmacist at Hartford Healthcare, Connecticut. Her research and clinical interests are in improving medication access for people who use substances and identifying and addressing social determinants of health.
No Relevant Financial Disclosures.
Joshua Lee, MD, MSc
Joshua D. Lee MD, MSc is a Professor in the departments of Population Health and Medicine/General Internal Medicine and Clinical Innovation at the NYU Grossman School of Medicine. He is Director of the NYU Fellowship in Addiction Medicine and Co-Director of DPH’s Section on Tobacco, Alcohol, and Drug Use. He is a clinician-researcher focused on addiction pharmacotherapies in primary care and criminal justice populations and leads the NYUGSOM Hub of the NIDA Justice and Community Opioid Innovation Network. He is a Science Advisor at Oar Health, an alcohol treatment provider.
Dislcosures: Indivior, in-kind study drug donation; Alkermes, in-kind study drug donation; Oar Health, Clinical Advisor
Lara Ray
PhD
Dr. Lara Ray received her PhD in Clinical Psychology from the University of Colorado at Boulder. Dr. Ray completed a predoctoral clinical internship at Brown University Medical School, where she stayed for a postdoctoral fellowship at the Brown University Center for Alcohol and Addiction Studies. After her postdoctoral fellowship, Dr. Ray joined the faculty at the UCLA Clinical Psychology Program, where she is now a Full Professor. Dr. Ray also has academic appointments at the UCLA Department of Psychiatry and Human Behavior and the UCLA Brain Research Institute. Dr. Ray has an active program of research on the clinical neuroscience of addiction. Her laboratory combines experimental psychopharmacology with behavioral genetic and neuroimaging methods to ascertain the mechanisms underlying addictive disorders in humans and apply these insights to treatment development. Dr. Ray has over 250 peer-reviewed publications and book chapters. Her program of research is funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) as well as the National Institute on Drug Abuse (NIDA). Dr. Ray has received research excellence awards from the American Psychological Association (APA), the Research Society on Alcoholism (RSA), and the American College on Neuropsychopharmacology (ACNP).
No Relevant Financial Disclosures.
Raymond F Anton MD
Medical University of South Carolina
Dr. Anton is a Distinguished University Professor and senior investigator with over 25 years of research experience. He is considered an international expert in biologic markers of alcohol use as well as in new treatments for alcohol use disorders (AUD's), as evidenced by conducting over 15 clinical trials. He participated in PROJECT Match as well as being the chair of the COMBINE Study and first author of its publication in JAMA. His team also developed one of he first fMRI alcohol cue tasks showing activation in salient brain reward systems that could be blocked by medications. As a current holder of a Senior Scientist Career and Mentoring Award (K05) he has used that support to integrate genetics and neuroimaging into his clinical trial work. His group has begun to bring together the brain-imaging paradigm with genetics and pharmacogenetics, providing the best technology available to investigate alcohol effects on the human brain as they relate to alcoholism vulnerability and treatment.
No Relevant Financial Disclosures.
Carolyn Chan, MD
University of Cincinnati
Dr. Carolyn Chan is an Assistant Professor of Clinical Medicine, internist and addiction medicine physician at the University of Cincinnati College of Medicine. She currently is the Program Director of the UC Addiction Medicine Fellowship. Clinically she spends her time on inpatient addiction consult service, outpatient integrated primary care and addiction clinic, and precepts internal medicine residents. She is the co-host of The Curbsiders Addiction Medicine Podcast, which disseminates evidence-based addiction practices to a broad audience. Her scholarly work focuses on addiction education and the use of medical improvisation to teach communication skills.
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Certified Counselors: NBCC Contact Hours Not Offered American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
NAADAC: CE Credits not offered
Maintenance of Certification (MOC)/Continuing Certification Program (CCP)
This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
ABIM MOC Points: 5.25 Medical Knowledge | 5.25 Patient Safety
ABP MOC: 5.25 Lifelong Learning & Self-Assessment
ABS Continuing Certification: 5.25 Accredited CME
ABA MOCA 2.0®*: 5.25 Lifelong Learning | 5.25 Patient Safety
Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.
American Board of Addiction Medicine (ABAM)
American Board of Preventative Medicine (ABPM)
American Board of Psychiatry and Neurology (ABPN)
Royal College of Physicians and Surgeons of Canada (RCPSC)
Certificates for other professions
All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1224.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
See the attached pdf for a list of disclosures.
American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
MOCA 2.0® is a trademark of the American board of Anesthesiology®.
This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.
The complete list of disclosures and designation statements are linked below.
This 30-minute case-based discussion equips behavioral health professionals with practical strategies to identify, assess, and treat co-occurring problem gambling and alcohol use disorder, applying key concepts to real-world scenarios to address their interconnected risks and improve integrated care.
Gambling and Alcohol Use Disorder
Host: National Council on Mental Wellbeing
Recorded: May 21, 2026 Enduring Training
Overview
This case-based discussion will equip behavioral health professionals with strategies to better identify, assess and treat individuals experiencing these co-occurring conditions. Problem gambling and alcohol use disorder (AUD) frequently co-occur, amplifying risk, severity and barriers to recovery for both conditions. Individuals experiencing one condition are significantly more likely to experience the other, and high comorbidity rates are commonly reported in both clinical and population studies. As access to gambling, including sports betting, continues to expand across the U.S., behavioral health professionals are increasingly encountering clients who are navigating both conditions simultaneously. Despite the overlap, gambling disorder and AUD are commonly treated in isolation from one another. This treatment gap can limit effective care for both conditions, ignoring the fact that the two exacerbate and reinforce one another (for example, using alcohol to cope with gambling losses or gambling under the influence of alcohol). Through interactive case discussions, participants will apply key concepts to real-world clinical scenarios, exploring triggers, coping strategies and values-based behavioral substitutions.
The target audience for this introductory level activity includes: All types of healthcare professionals.
The ACGME Competencies include: Patient Care and Procedural Skills, and Systems-based Practice
Learning Objectives
Upon completion, learners will be able to:
Describe problem gambling prevalence and comorbidity with alcohol use disorder
Identify one empirically supported psychotherapeutic treatment for gambling disorder
Name two empirically supported assessment tools to screen for gambling problems
Registration Deadline: 08/30/2027
Close Access Date: 09/30/2027
Instructions
Click on the Contents tab to begin this activity.
Click View On-Demand Session to watch the training.
Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click Claim Certificate of Completion to view/print certificate.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact pcssmaud@asam.org.
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This 75-minute case-based discussion explains practical strategies for engaging patients who feel uncertain or ambivalent about alcohol use disorder treatment, using motivational interviewing (MI) techniques to support autonomy and assess readiness to change.
Engaging Patients Expressing Ambivalence Towards Alcohol Use Disorder Treatment
Host: Addiction Technology Transfer Center
Recorded: May 7, 2026 Enduring Training
Overview
This 75-minute case-based discussion explains practical strategies for engaging patients who feel uncertain or ambivalent about alcohol use disorder treatment, using motivational interviewing (MI) techniques to support autonomy and assess readiness to change. By applying the MI OARS framework, learners gain a plethora of tools to guide focused, goal-oriented conversations that encourage positive behavior change and increase readiness to accept behavioral and/or medical treatment referrals.
The target audience for this introductory level activity includes: All types of healthcare professionals.
The ACGME Competencies include: Patient Care and Procedural Skills, and Systems-based Practice
Learning Objectives
Upon completion, learners will be able to:
Describe at least three strategies to engage patients in conversations about their alcohol use.
List at least two motivational interviewing (MI) micro-skills (e.g., OARS Framework) that can be used with patients who are ambivalent about making a health promoting change in their alcohol consumption.
Explain at least two ways that the MI OARS Framework can be used to encourage goal-directed conversations that result in positive behavior change.
Registration Deadline: 08/30/2027
Close Access Date: 09/30/2027
Instructions
Click on the Contents tab to begin this activity.
Click View On-Demand Session to watch the training.
Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click Claim Certificate of Completion to view/print certificate.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact pcssmaud@asam.org.
Beth A. Rutkowski, MPH
UCLA Integrated Substance Use and Addiction Programs | Pacific Southwest Addiction Technology Transfer Center
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This 75-minute webinar equips prescribers with practical, evidence-based tools to help patients initiate and sustain engagement in alcohol use disorder treatment through skill practice and real-world case scenarios.
Behavior Change Tools for Prescribers Treating Alcohol Use Disorder
Host: American Society of Addiction Medicine
Recorded: April 26, 2026 Enduring Training
Overview
This webinar introduces prescribers to practical, evidence-based strategies that help patients initiate and stay engaged in alcohol use disorder treatment. Through skill demonstrations and role-play using real patient cases, participants explore tools like Behavior Chain Analysis, the RAC Framework, safety planning, and urge surfing. These simple, actionable templates are designed for prescribers without behavioral health specialization who want effective ways to support recovery and improve treatment outcomes. This training is a recording of a live session hosted at ASAM's 57th annual conference.
The target audience for this introductory level activity includes: Prescribers
The ACGME Competencies include: Patient Care and Procedural Skills, and Systems-based Practice
Learning Objectives
Upon completion, learners will be able to:
Understand how prescribers can effectively integrate behavior change strategies with pharmacologic treatment for patients with AUD to enhance engagement, support sustained recovery, and improve retention in care.
Utilize Behavior Chain Analysis, RAC Framework, safety and relapse prevention planning, and urge surfing to develop personalized strategies that support behavior change and treatment adherence in patients with AUD.
Demonstrate how to utilize behavior change strategies in the treatment of patients with AUD, including adapting approaches for a variety of care settings.
Registration Deadline: 08/30/2027
Close Access Date: 09/30/2027
Instructions
Click on the Contents tab to begin this activity.
Click View On-Demand Session to watch the training.
Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click Claim Certificate of Completion to view/print certificate.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact pcssmaud@asam.org.
Carla B. Marienfeld, MD, DFAPA, DFASAM:
Carla Marienfeld, MD, is an addiction psychiatrist and Clinical Professor at the University of California, San Diego (UCSD). She edited two books: Motivational Interviewing for Clinical Practice and Absolute Addiction Psychiatry Review: An Essential Board Exam Study Guide. She has been highly involved in the education of colleagues and trainees, and she is the fellowship director for the UCSD Addiction Psychiatry Fellowship. Dr. Marienfeld completed a fellowship in addiction psychiatry and residency training in psychiatry at Yale University. Her medical degree with honors is from Baylor College of Medicine in Houston, Texas. Dr. Marienfeld is a consultant for and has stock in CARI Health.
John O'Neil, LCSW, LADC
Social Worker
Yale Addiction Medicine Consult Service
John is a Licensed Clinical Social Worker and Licensed Alcohol and Drug Counselor working as the Social Worker for the Yale Addiction Medicine Consult Service where he provides clinical support for patients who suffer from serious medical problems related to substance abuse disorders. He has been at Yale since 2022 and also works as a clinician in group practice where he focuses on clients with AUD. His education includes a Drug and Alcohol Recovery Counselor (DARC) Certificate from Gateway Community College and an MSW from Southern Connecticut State University, as well as a BS in Marketing and MBA from Ball State University. John’s experience in addiction treatment includes work for Aware In Home Addiction Treatment and Residential Treatment Units of Recovery Network of Programs.
John also worked extensively in marketing, advertising, and retail photo management. His work in marketing consulting included working closely with Dr. C. Everett Koop on Dr. Koop’s Shape Up America! Campaign for Healthy Weight which John likes to consider amends for all his earlier work marketing Canada Dry, Pepsi, Kentucky Fried Chicken, and McDonald’s products. He is a veteran of the Vietnam War where he served as a First Lieutenant in the U.S. Army Field Artillery and was awarded a Bronze Star for Service.
Eve N. Lasswell, PsyD
Psychologist
University of California San Diego
Eve Lasswell, PsyD, is a licensed clinical psychologist who treats adults with substance use and co-occurring disorders. Dr. Lasswell is part of UC San Diego Health's Substance Treatment and Recovery program, which uses a harm-reduction approach to provide care for all stages of recovery from substance use disorders. She treats patients with co-occurring mental health and substance abuse disorders ad helps adults recover from addiction by encouraging behaviors that build wellness and emotional resilience.
In addition, she has experience helping people with post traumatic stress disorder (PTSD), depression, and anxiety, as well as concerns related to role transitions and interpersonal relationships.
Dr. Lasswell also has experience providing care to diverse patient populations, including those with ethnic backgrounds different from her own, LGBTQIA+ individuals, and current and former members of the US military.
Her research aims to improve outcomes for people with substance use disorders, and improve access to mental health services for the underserved.
Dr. Lasswell is Board-Certified in Addiction Psychology by the American Board of Professional Psychology. She completed a postdoctoral fellowship in addiction treatment at Veterans Affairs Salt Lake City Health Care System. She earned her doctorate in clinical psychology at Indiana State University.
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.